Denali Therapeutics Financial Overview
Denali Therapeutics's market cap is currently €2.23B. The company's EPS TTM is €-0.632328927; its P/E ratio is -5.40; Denali Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is €-0.64. See an overview of income statement, balance sheet, and cash flow financials.
